Expression and Correlation of Cell-Free cIAP-1 and cIAP-2 mRNA in Breast Cancer Patients: A Study from India

Table 4

Association of clinicopathological features with cIAP-2 mRNA expression in breast cancer patients.

Variables	cIAP-2 mRNA expression
	Mean ± SD	value
Overall expression	8.76 ± 7.16	—
Age
<45	9.43 ± 8.85	0.44
>45	10.97 ± 9.98
TNM stage
Stage I	7.80 ± 6.42	0.0002
Stage II	8.09 ± 8.00
Stage III	7.97 ± 3.94
Stage IV	12.85 ± 4.42
Distant metastases
Yes	12.85 ± 4.42	<0.0001
No	8.04 ± 7.33
Lymph node involvement
Yes	9.37 ± 8.18	0.83
No	8.80 ± 4.44
Menopause
Yes	9.46 ± 8.47	0.52
No	7.62 ± 4.09
ER expression
Yes	9.03 ± 7.59	0.73
No	8.89 ± 7.33
PR expression
Yes	8.85 ± 7.94	0.87
No	8.07 ± 6.73
HER2 expression
Yes	9.30 ± 7.12	0.12
No	8.15 ± 7.24
Smoking
Yes	8.96 ± 8.09	0.43
No	8.24 ± 3.93
Alcoholism
Yes	9.08 ± 8.30	0.54
No	8.07 ± 3.77